{"data":{"ModuleTitle":{"label":"Module Title","value":"Company Description"},"CompanyName":{"label":"Company Name","value":"Certara, Inc."},"Symbol":{"label":"Symbol","value":"CERT"},"Address":{"label":"Address","value":"100 OVERLOOK CENTER,SUITE 101, PRINCETON, New Jersey, 08540, United States"},"Phone":{"label":"Phone","value":"+1 609 716-7900"},"Industry":{"label":"Industry","value":"Computer Software: Prepackaged Software"},"Sector":{"label":"Sector","value":"Technology"},"Region":{"label":"Region","value":"North America"},"CompanyDescription":{"label":"Company Description","value":"Certara Inc accelerate medicines to patients using biosimulation software and technology to transform traditional drug discovery and development. It provides modeling and simulation, regulatory science, and assessment software and services to help clients reduce clinical trial, accelerate regulatory approval and increase patient access to medicines. The group has a business presence in the United States, EMEA and other regions, of which a majority of revenue is derived from the United States."},"CompanyUrl":{"label":"Company Url","value":"https://www.certara.com"},"KeyExecutives":{"label":"Key Executives","value":[{"name":"Amin Rostami-Hodjegan","title":"Chief Scientific Officer"},{"name":"Max Kanevsky","title":"Chief Technology Officer"},{"name":"William F. Feehery","title":"Chief Executive Officer & Director"}]}},"message":null,"status":{"rCode":200,"bCodeMessage":null,"developerMessage":null}}